ESR1 and breast carcinoma: Taken together, these findings establish that ENDX not only inhibits proliferation, but at higher concentrations, induces apoptosis of ERα+ breast cancer cells, and this may occur in part through inhibition of PKCβ1 and the resulting decrease in AKT kinase activity.